<DOC>
	<DOCNO>NCT00863226</DOCNO>
	<brief_summary>The purpose study see device call Resonator help improve aspect health quality life relevant patient Parkinson 's disease .</brief_summary>
	<brief_title>Study Application Magnetic Fields Treatment Parkinson 's Disease</brief_title>
	<detailed_description>This clinical trial evaluate new non-invasive , non-significant risk , device therapy adjuvant symptomatic treatment sign symptoms Parkinson 's Disease ( PD ) . The device utilizes patent technology involve extremely low level electromagnetic field .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Idiopathic Parkinson 's Disease Stable optimize antiPD drug least 4 week PDQ39 Summary Index 15 45 Ambulatory Willing maintain regular medication regime throughout study Able abstain start new treatment improve PD symptom course study . No prior surgical intervention Parkinson 's Disease Nondemented Minimum 30 year age , old 85 Capable give full write consent Atypical Parkinsonism progressive supranuclear palsy , multiple system atrophy , CBDG etc . Subjects may follow : active brain tumor , stroke , hydrocephalus , neurologic nonneuro problem may affect symptomatic expression patient parkinsonism . Consumption medication produce drug induce parkinsonism Chronic pain associate PD Current past history major psychiatric disturbance No typical nontypical antipsychotic treatment drug induce psychosis . Chronic fatigue Epilepsy history epilepsy Seizures take medication epilepsy HIV autoimmune disorder History ECT Uncontrolled hypertension Advanced pulmonary disease Unstable cardiac disease Prior surgical intervention Parkinson 's disease Prosthetics implant comprise ferrous metal Pacemaker , vagus nerve stimulators , functional electrical stimulators commonly use pain Pregnant , breast feeding planning pregnancy prior study end Dementia , developmental disability , psychiatric disorder cognitive impairment Any significant medical condition may require alteration medical therapy study , major medical condition may interfere study activity .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Quality Life issue Parkinson 's disease</keyword>
</DOC>